Skip to main content

Table 1 Genotype frequencies of rs6573816 and its association with glioma risk

From: Identification of a RAD51B enhancer variant for susceptibility and progression to glioma

Genotypea

Patients (n = 402)

No. (%)

Controls (n = 654)

No. (%)

ORb (95%CI)

P

GG

350 (87.94)

540 (83.20)

1.00 (reference)

 

GC

45 (11.31)

103 (15.87)

0.66 (0.45–0.97)

0.034

CC

3 (0.75)

6 (0.93)

1.03 (0.25–4.22)

0.964

GC + CC vs. GG

  

0.68 (0.47–0.99)

0.041

  1. OR odds ratios, CI confidence interval
  2. aSome samples failed to genotype
  3. bData were calculated by logistic regression with adjustment for age and sex